Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lizhu Lin

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Oncology|October 20, 2022
Circadian clock as a possible control point in colorectal cancer progression (Review)Xiwu Rao, Lizhu Lin
Pharmaceutical Biology|September 10, 2022
<i>Astragalus</i> polysaccharide (APS) attenuated PD-L1-mediated immunosuppression via the miR-133a-3p/MSN axis in HCCLihua He, Kecheng Xu, Lizhi Niu, et al.
Neuro Endocrinology Letters|October 29, 2021
Coexisting of myasthenia gravis and fulminant myocarditis induced by nivolumab in a patient with ureteral epithelial cancerJing Zhang, Jiayin Li, Linzhu Zhai, et al.
Scientific Reports|April 22, 2021
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axisRui Han, Hongxing Yang, Lingeng Lu, et al.
Journal of Lipid Research|February 12, 2026
A Novel Immune-Isolation Method for Direct Quantification of Triglycerides Associated with Lipoprotein(a)Lizhu Lin, Fei Su, Calvin Yeang, et al.
Medicine|October 4, 2018
Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature reviewJietao Lin, Yang Cao, Ling Yu, et al.
Head & Neck|November 30, 2023
Risk factors for sarcopenia in patients with head and neck cancerChen Liu, Ling Cheng, Wenfeng Ye, et al.
Journal of Lipid Research|February 25, 2026
Analytical Validation of Direct Lipoprotein(a)-Cholesterol AssaySantica M Marcovina, Spenser Smith, Lizhu Lin, et al.
Journal of Cellular and Molecular Medicine|February 3, 2019
MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1Peng Li, Zhiwei Xiao, Jiajun Luo, et al.
BMC Cancer|December 7, 2019
Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case reportJieshan Guan, Zhijie Luo, Zhiwei Xiao, et al.
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Oncology|October 20, 2022
Circadian clock as a possible control point in colorectal cancer progression (Review)Xiwu Rao, Lizhu Lin
Pharmaceutical Biology|September 10, 2022
<i>Astragalus</i> polysaccharide (APS) attenuated PD-L1-mediated immunosuppression via the miR-133a-3p/MSN axis in HCCLihua He, Kecheng Xu, Lizhi Niu, et al.
Neuro Endocrinology Letters|October 29, 2021
Coexisting of myasthenia gravis and fulminant myocarditis induced by nivolumab in a patient with ureteral epithelial cancerJing Zhang, Jiayin Li, Linzhu Zhai, et al.
Scientific Reports|April 22, 2021
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axisRui Han, Hongxing Yang, Lingeng Lu, et al.
Journal of Lipid Research|February 12, 2026
A Novel Immune-Isolation Method for Direct Quantification of Triglycerides Associated with Lipoprotein(a)Lizhu Lin, Fei Su, Calvin Yeang, et al.
Medicine|October 4, 2018
Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature reviewJietao Lin, Yang Cao, Ling Yu, et al.
Head & Neck|November 30, 2023
Risk factors for sarcopenia in patients with head and neck cancerChen Liu, Ling Cheng, Wenfeng Ye, et al.
Journal of Lipid Research|February 25, 2026
Analytical Validation of Direct Lipoprotein(a)-Cholesterol AssaySantica M Marcovina, Spenser Smith, Lizhu Lin, et al.
Journal of Cellular and Molecular Medicine|February 3, 2019
MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1Peng Li, Zhiwei Xiao, Jiajun Luo, et al.
BMC Cancer|December 7, 2019
Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case reportJieshan Guan, Zhijie Luo, Zhiwei Xiao, et al.
Pageof 15